Rod Amir Rahimi, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Th2 Cells | 2 | 2025 | 1075 | 1.130 |
Why?
|
Immunologic Memory | 4 | 2020 | 1375 | 1.050 |
Why?
|
Hypersensitivity | 3 | 2025 | 1168 | 0.970 |
Why?
|
T-Lymphocyte Subsets | 3 | 2025 | 1811 | 0.860 |
Why?
|
Helminths | 1 | 2022 | 39 | 0.790 |
Why?
|
Transforming Growth Factor beta | 5 | 2019 | 1995 | 0.550 |
Why?
|
Respiratory Tract Infections | 1 | 2022 | 1008 | 0.460 |
Why?
|
Chemokines | 1 | 2018 | 956 | 0.440 |
Why?
|
Lung Diseases | 1 | 2022 | 1940 | 0.390 |
Why?
|
Immunity, Innate | 2 | 2022 | 3081 | 0.360 |
Why?
|
Muscle Weakness | 1 | 2012 | 413 | 0.330 |
Why?
|
Physical Therapy Modalities | 1 | 2012 | 533 | 0.310 |
Why?
|
Lampreys | 1 | 2008 | 32 | 0.310 |
Why?
|
Lung | 4 | 2022 | 10033 | 0.300 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 434 | 0.260 |
Why?
|
Respiratory Insufficiency | 1 | 2012 | 1240 | 0.220 |
Why?
|
Dendritic Cells | 3 | 2025 | 2747 | 0.200 |
Why?
|
Receptors, Pattern Recognition | 1 | 2022 | 81 | 0.190 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2012 | 1480 | 0.180 |
Why?
|
Animals | 17 | 2025 | 168764 | 0.180 |
Why?
|
Pyroglyphidae | 1 | 2020 | 94 | 0.170 |
Why?
|
Thorax | 1 | 2022 | 554 | 0.160 |
Why?
|
Trans-Activators | 1 | 2009 | 2850 | 0.160 |
Why?
|
Allergens | 3 | 2023 | 1436 | 0.160 |
Why?
|
Intensive Care Units | 1 | 2012 | 3800 | 0.160 |
Why?
|
Transcription Factors | 2 | 2009 | 12131 | 0.160 |
Why?
|
Lung Injury | 1 | 2023 | 430 | 0.150 |
Why?
|
Mucus | 1 | 2020 | 346 | 0.150 |
Why?
|
Myofibroblasts | 2 | 2017 | 229 | 0.150 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2023 | 3111 | 0.150 |
Why?
|
Cytokines | 2 | 2025 | 7421 | 0.140 |
Why?
|
Immunologic Surveillance | 1 | 2018 | 92 | 0.140 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2008 | 3607 | 0.140 |
Why?
|
Uncertainty | 1 | 2022 | 761 | 0.140 |
Why?
|
Arteritis | 1 | 2019 | 159 | 0.140 |
Why?
|
Receptors, Cytokine | 1 | 2018 | 258 | 0.140 |
Why?
|
Mammals | 1 | 2022 | 1125 | 0.130 |
Why?
|
Chemokine CCL2 | 1 | 2019 | 602 | 0.130 |
Why?
|
Immunomodulation | 1 | 2020 | 547 | 0.130 |
Why?
|
Lymphoid Tissue | 1 | 2018 | 444 | 0.130 |
Why?
|
Lectins, C-Type | 1 | 2019 | 592 | 0.130 |
Why?
|
Carrier Proteins | 1 | 2009 | 4913 | 0.120 |
Why?
|
Pneumonia | 2 | 2020 | 2157 | 0.120 |
Why?
|
Receptors, Chemokine | 1 | 2018 | 651 | 0.120 |
Why?
|
Fibroblasts | 3 | 2010 | 4159 | 0.110 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2013 | 178 | 0.100 |
Why?
|
Terminology as Topic | 1 | 2020 | 1534 | 0.100 |
Why?
|
Aniline Compounds | 1 | 2017 | 1075 | 0.100 |
Why?
|
Signal Transduction | 5 | 2019 | 23601 | 0.090 |
Why?
|
Smad Proteins | 2 | 2010 | 157 | 0.090 |
Why?
|
Oncogene Proteins v-erbB | 1 | 2010 | 17 | 0.090 |
Why?
|
Apoptosis | 3 | 2017 | 9514 | 0.090 |
Why?
|
Particulate Matter | 1 | 2022 | 2624 | 0.090 |
Why?
|
Inflammation | 3 | 2025 | 10850 | 0.080 |
Why?
|
Cell Movement | 2 | 2019 | 5194 | 0.080 |
Why?
|
Pulmonary Fibrosis | 1 | 2013 | 503 | 0.080 |
Why?
|
Mice, Inbred C57BL | 4 | 2020 | 22332 | 0.080 |
Why?
|
Oncogene Protein v-akt | 1 | 2009 | 130 | 0.080 |
Why?
|
Sulfonamides | 1 | 2017 | 1984 | 0.070 |
Why?
|
Transcription, Genetic | 2 | 2020 | 7599 | 0.070 |
Why?
|
Dogs | 2 | 2010 | 3822 | 0.070 |
Why?
|
Gene Duplication | 1 | 2008 | 317 | 0.070 |
Why?
|
Cell Differentiation | 1 | 2025 | 11641 | 0.070 |
Why?
|
Biochemistry | 1 | 2007 | 115 | 0.070 |
Why?
|
Neural Crest | 1 | 2008 | 278 | 0.070 |
Why?
|
HeLa Cells | 2 | 2010 | 3067 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4642 | 0.060 |
Why?
|
Cell Proliferation | 1 | 2020 | 10429 | 0.060 |
Why?
|
Mesoderm | 1 | 2007 | 679 | 0.060 |
Why?
|
Macrophages | 1 | 2019 | 5772 | 0.060 |
Why?
|
Body Patterning | 1 | 2008 | 633 | 0.060 |
Why?
|
Asthma | 1 | 2023 | 6270 | 0.060 |
Why?
|
Lymphoma | 1 | 2012 | 1897 | 0.050 |
Why?
|
Activities of Daily Living | 1 | 2012 | 2415 | 0.050 |
Why?
|
Cystic Fibrosis | 1 | 2012 | 1287 | 0.050 |
Why?
|
Lung Transplantation | 1 | 2012 | 1311 | 0.050 |
Why?
|
Epithelium | 1 | 2007 | 1599 | 0.050 |
Why?
|
Humans | 10 | 2025 | 765968 | 0.050 |
Why?
|
Receptor, erbB-2 | 1 | 2013 | 2593 | 0.050 |
Why?
|
Multiprotein Complexes | 1 | 2009 | 1107 | 0.050 |
Why?
|
Methylmercury Compounds | 1 | 2003 | 103 | 0.050 |
Why?
|
Oncogenes | 1 | 2007 | 1235 | 0.050 |
Why?
|
Enzyme Activation | 1 | 2007 | 3586 | 0.050 |
Why?
|
Sirolimus | 1 | 2009 | 1545 | 0.050 |
Why?
|
Mice | 7 | 2023 | 81819 | 0.050 |
Why?
|
Phylogeny | 1 | 2008 | 2832 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10261 | 0.040 |
Why?
|
Ganglia, Spinal | 1 | 2003 | 529 | 0.040 |
Why?
|
Evolution, Molecular | 1 | 2008 | 1889 | 0.040 |
Why?
|
Integrin alphaV | 1 | 2019 | 54 | 0.040 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2009 | 2056 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2009 | 2878 | 0.040 |
Why?
|
Autoantigens | 1 | 2023 | 883 | 0.040 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2023 | 1441 | 0.040 |
Why?
|
Tumor Suppressor Proteins | 1 | 2009 | 2796 | 0.040 |
Why?
|
Phosphorylation | 1 | 2009 | 8278 | 0.040 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2012 | 3247 | 0.040 |
Why?
|
Epithelial Cells | 1 | 2009 | 3681 | 0.030 |
Why?
|
Epidermis | 1 | 2019 | 538 | 0.030 |
Why?
|
Mitochondrial Membranes | 1 | 2017 | 184 | 0.030 |
Why?
|
Dermis | 1 | 2017 | 204 | 0.030 |
Why?
|
Candida albicans | 1 | 2019 | 377 | 0.030 |
Why?
|
bcl-X Protein | 1 | 2017 | 414 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2023 | 1624 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2020 | 1866 | 0.030 |
Why?
|
Autoimmunity | 1 | 2023 | 1354 | 0.030 |
Why?
|
Antioxidants | 1 | 2023 | 1670 | 0.030 |
Why?
|
Vasculitis | 1 | 2019 | 527 | 0.030 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2019 | 537 | 0.030 |
Why?
|
Inflammasomes | 1 | 2019 | 543 | 0.030 |
Why?
|
Proteins | 1 | 2009 | 5995 | 0.030 |
Why?
|
Scleroderma, Systemic | 1 | 2017 | 346 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2019 | 2060 | 0.030 |
Why?
|
Interleukin-1beta | 1 | 2019 | 1028 | 0.030 |
Why?
|
Mechanotransduction, Cellular | 1 | 2017 | 540 | 0.030 |
Why?
|
Leukocytes | 1 | 2020 | 2027 | 0.020 |
Why?
|
Bleomycin | 1 | 2013 | 491 | 0.020 |
Why?
|
Paracrine Communication | 1 | 2013 | 277 | 0.020 |
Why?
|
Pulmonary Gas Exchange | 1 | 2013 | 389 | 0.020 |
Why?
|
Aorta | 1 | 2019 | 2028 | 0.020 |
Why?
|
Models, Biological | 1 | 2007 | 9443 | 0.020 |
Why?
|
Swiss 3T3 Cells | 1 | 2010 | 6 | 0.020 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2013 | 615 | 0.020 |
Why?
|
Feedback, Physiological | 1 | 2013 | 480 | 0.020 |
Why?
|
Epidermal Growth Factor | 1 | 2013 | 698 | 0.020 |
Why?
|
Fibrosis | 1 | 2017 | 2070 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2017 | 1727 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2010 | 381 | 0.020 |
Why?
|
Monocytes | 1 | 2019 | 2595 | 0.020 |
Why?
|
Phenotype | 1 | 2007 | 16721 | 0.020 |
Why?
|
Drug Interactions | 1 | 2013 | 1417 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2019 | 3454 | 0.020 |
Why?
|
Cell Line | 2 | 2013 | 15543 | 0.020 |
Why?
|
Coronary Vessels | 1 | 2019 | 3096 | 0.020 |
Why?
|
Cell Survival | 1 | 2017 | 5747 | 0.020 |
Why?
|
Benzamides | 1 | 2013 | 1377 | 0.020 |
Why?
|
Gene Knockout Techniques | 1 | 2010 | 798 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9550 | 0.020 |
Why?
|
Quinazolines | 1 | 2013 | 1364 | 0.020 |
Why?
|
Neutrophils | 1 | 2019 | 3776 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2019 | 3584 | 0.020 |
Why?
|
Skin | 1 | 2019 | 4489 | 0.020 |
Why?
|
Mitochondria | 1 | 2017 | 3673 | 0.010 |
Why?
|
Up-Regulation | 1 | 2013 | 4137 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2010 | 3089 | 0.010 |
Why?
|
Neurons | 1 | 2003 | 9525 | 0.010 |
Why?
|
PC12 Cells | 1 | 2003 | 317 | 0.010 |
Why?
|
Piperazines | 1 | 2013 | 2549 | 0.010 |
Why?
|
Neurites | 1 | 2003 | 389 | 0.010 |
Why?
|
Pyrimidines | 1 | 2013 | 3047 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2010 | 2844 | 0.010 |
Why?
|
Male | 2 | 2017 | 363698 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18293 | 0.010 |
Why?
|
Adult | 1 | 2012 | 223044 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2013 | 5696 | 0.010 |
Why?
|
Female | 2 | 2012 | 396112 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2003 | 8102 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2003 | 10729 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2003 | 18973 | 0.000 |
Why?
|
Rats | 1 | 2003 | 23707 | 0.000 |
Why?
|
Pregnancy | 1 | 2003 | 30260 | 0.000 |
Why?
|